Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients.
about
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's diseaseCobalamin deficiency, hyperhomocysteinemia, and dementiaRational pharmacological approaches for cognitive dysfunction and depression in Parkinson's diseaseDementia medications and risk of falls, syncope, and related adverse events: meta-analysis of randomized controlled trials.The combination of homocysteine and C-reactive protein predicts the outcomes of Chinese patients with Parkinson's disease and vascular parkinsonism.Effects of cholinesterase inhibitors in Parkinson's disease dementia: a review of clinical data.Diagnosis and management of Parkinson's disease dementia.Rivastigmine in Parkinson's disease dementia.Drug therapy in patients with Parkinson's disease.BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline.
P2860
Q24201307-32072583-BE22-4673-B08C-FE9DBBF23A94Q24609123-B3ED1174-F9FF-469B-9D0D-6E7552A570B7Q28084380-AE76A9C0-478F-4F25-9B6B-574217E74185Q33160127-044E686D-4CE7-4623-9D5F-A9850A5879EFQ33893957-7F458F92-0886-4A46-85E7-2D66BFE3D127Q34032505-29EF0F91-F13D-43D2-A2BC-F2097CCA6A82Q37281128-1280172B-46B9-4942-9C70-306A3A55656FQ37556550-2863FBEB-FED4-4AAA-A682-7AE2807792A6Q38064971-CE403891-BB49-4DFE-AF00-73EE6A4D2676Q46249334-AA26C850-3077-4CFF-9D83-9959E0D3105A
P2860
Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Rivastigmine versus placebo in ...... n's disease dementia patients.
@en
Rivastigmine versus placebo in ...... n's disease dementia patients.
@nl
type
label
Rivastigmine versus placebo in ...... n's disease dementia patients.
@en
Rivastigmine versus placebo in ...... n's disease dementia patients.
@nl
prefLabel
Rivastigmine versus placebo in ...... n's disease dementia patients.
@en
Rivastigmine versus placebo in ...... n's disease dementia patients.
@nl
P50
P921
P356
P1433
P1476
Rivastigmine versus placebo in ...... n's disease dementia patients.
@en
P2093
Chuanchieh Hsu
Roger M Lane
P2860
P304
P356
10.1002/MDS.21997
P407
P577
2008-08-01T00:00:00Z